# Study to Evaluate the Safety and Efficacy of Adeno-IFN Gamma in Cutaneous B-cell Lymphoma

> **NCT00394693** · PHASE2 · COMPLETED · sponsor: **Transgene** · enrollment: 13 (actual)

## Conditions studied

- Lymphoma, B-Cell

## Interventions

- **GENETIC:** Adenovirus Interferon gamma

## Key facts

- **NCT ID:** NCT00394693
- **Lead sponsor:** Transgene
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2010-01
- **Final completion:** 2010-04
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2014-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00394693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00394693, "Study to Evaluate the Safety and Efficacy of Adeno-IFN Gamma in Cutaneous B-cell Lymphoma". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00394693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*